Article 16 Sep 2015 FDA Releases Long-Awaited Biological Naming Draft Guidance And Proposed Rule United States Healthcare
Article 02 Jul 2015 FDA Announces Delay In Enforcing DSCSA Requirements For Dispensers United States Healthcare
Article 30 Apr 2015 FDA Issues Draft Guidance Addressing Reliance On Ex-U.S. Clinical Data In Medical Device Premarket Submissions United States Healthcare
Article 26 Mar 2015 FDA Issues Draft Guidance On Use Of Electronic Informed Consent In Clinical Trials United States Healthcare
Article 23 Mar 2015 FDA Issues Revised Draft Guidance On Disclosures Of Risk Information In Consumer-Friendly Print Advertisements And Promotional Labeling United States Healthcare
Article 12 Feb 2015 FDA Will Not Enforce Regulatory Controls For Medical Device Data Systems And Two Other Health IT Devices United States Healthcare
Article 05 Feb 2015 FDA Issues Draft Guidance On General Wellness Devices And On Medical Device Accessories United States Healthcare
Article 22 Jul 2014 FDA Issues Draft Guidance On Communications Over Internet And Social Media Platforms United States Healthcare
Article 26 Jun 2014 FDA Advises It Will Not Enforce Regulatory Controls For Low-Risk Medical Information Technology Devices United States Healthcare
Article 18 Jun 2014 FDA Issues Distribution Of Risk Information Draft Guidance Amid Asserted Push To Release Guidance On Manufacturer Communications United States Healthcare
Article 12 Apr 2014 FDA, ONC and FCC Report Outlines Proposed Health Information Technology Regulatory Strategy and Recommendations United States Healthcare
Article 26 Mar 2014 HHS And GAO Reports Highlight Need To Address Drug Shortages United States Healthcare
Article 03 Mar 2014 FDA Releases Final Guidance on "Dear Doctor" Letters That Omits Controversial Behavior Modification Assessment Provision United States Healthcare
Article 29 Jan 2014 FDA Issues Draft Guidance Addressing Postmarket Submission Requirements For Internet-based Promotional Materials United States Healthcare
Article 25 Jan 2014 New Law Extends Federal Oversight Of Compounding Pharmacies, Establishes National Drug Track-and-Trace Requirements United States Healthcare
Article 09 May 2013 Draft Guidance Outlines Recommendations For Formal Meetings Between FDA And Biosimilar Sponsors And Applicants United States Healthcare
Article 18 Dec 2012 Federal Court Vacates Conviction For Truthful Off-Label Promotion Of FDA-Approved Drug United States Healthcare
Article 09 Aug 2012 New Flexibility For Pharmaceutical And Medical Device Companies In Massachusetts, But At A Price United States Healthcare
Article 16 Jul 2012 President Obama Signs Bipartisan FDA User Fee Legislation United States Healthcare
Article 27 Jun 2012 FCC Announces Rulemaking Enabling Remote Monitoring Of Health Care Data United States Healthcare